Fortis Healthcare Limited has informed the Exchange about revision in Policy on Related Party Transactions and Policy for Prevention of Insider Trading.
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare's Board of Directors, at a meeting held on May 20, 2025, approved revisions to two key governance policies: the Policy on Related Party Transactions (now Version 8.0) and the Policy for Prevention of Insider Trading (now Version 7). The Related Party Transactions policy outlines the framework for approval, review, and reporting of transactions with related parties, including thresholds for material transactions (₹1,000 crore or 10% of consolidated turnover, whichever is lower). The Insider Trading policy establishes rules around trading windows, designated persons, communication of unpublished price sensitive information (UPSI), and digital database maintenance. Both policies have been updated to align with SEBI's Listing Regulations and Prohibition of Insider Trading Regulations. The Board meeting concluded at 18:55 IST, and the full updated policy documents have been filed with the stock exchanges.
This is a routine governance and regulatory compliance update with no direct impact on business operations, financials, or shareholder value. It reinforces Fortis's internal controls around related party dealings and insider trading, which is positive for corporate governance standards.